Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Male breast cancer

(2010) César Gómez-Raposo et al.   CANCER TREATMENT REVIEWS

A Large Study ofAndrogen ReceptorGermline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

(2010) Sara Lindström et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Risk of breast cancer in male BRCA2 carriers

(2010) D. G. R. Evans et al.   JOURNAL OF MEDICAL GENETICS

Male breast cancer: An update in diagnosis, treatment and molecular profiling

(2010) Susan Onami et al.   MATURITAS

Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database

(2009) Louise A. Brinton et al.   BREAST CANCER RESEARCH AND TREATMENT

Urban–rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt

(2009) Subhojit Dey et al.   BREAST CANCER RESEARCH AND TREATMENT

Length of Androgen Receptor-CAG Repeats in Fertile and Infertile Egyptian Men

(2009) W. A. Badran et al.   JOURNAL OF ANDROLOGY

The changing patterns of bladder cancer in Egypt over the past 26 years

(2008) Ashley S. Felix et al.   CANCER CAUSES & CONTROL

Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: Possibilities for prevention

(2008) W ANWAR et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH